News
Filter
-
MRC Technology and Proximagen Collaborate to Develop Novel Therapeutics for Inflammatory and Autoimmune Disease
-
Dr. John Stageman Appointed Chair of the Board for MRC Technology
-
Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology
-
MRC Technology Announces Humanization of Anti-Tau Monoclonal Antibody for Alzheimer’s Disease Therapy
-
MRC Technology and AstraZeneca renew collaboration to identify novel targets for discovery research
-
Dementia Consortium wins One Nucleus BioNewsRound Award at ON Helix 2014
-
MRC Technology sells its melanocortin receptors programme to Pfizer Inc
-
MRC Technology and Daiichi Sankyo collaborate to identify novel targets for drug discovery
-
16 applications received for first Dementia Consortium deadline
-
MRC Technology and Chinese Academy of Science extend collaboration to identify new targets for drug discovery
-
UCB and UK’s MRC Technology sign exclusive license agreement for a fibrosis programme
-
£3m Dementia Consortium launched to boost dementia drug discovery
